{"id":21371,"date":"2026-07-02T12:09:04","date_gmt":"2026-07-02T08:09:04","guid":{"rendered":"https:\/\/medscriptum.org\/?p=21371"},"modified":"2026-07-02T12:12:18","modified_gmt":"2026-07-02T08:12:18","slug":"large-scale-study-taking-paracetamol-during-pregnancy-does-not-increase-the-risk-of-autism-or-adhd-in-children","status":"publish","type":"post","link":"https:\/\/medscriptum.org\/en\/large-scale-study-taking-paracetamol-during-pregnancy-does-not-increase-the-risk-of-autism-or-adhd-in-children\/","title":{"rendered":"Large-scale study: Taking paracetamol during pregnancy does not increase the risk of autism or ADHD in children"},"content":{"rendered":"<p data-path-to-node=\"3\">A new large-scale study analyzing two decades of accumulated medical data has confirmed that taking paracetamol (commonly known as Tylenol in the US) during pregnancy does not increase the risk of children developing autism or attention-deficit\/hyperactivity disorder (ADHD). Published in the prestigious scientific journal <i data-path-to-node=\"3\" data-index-in-node=\"324\">JAMA Internal Medicine<\/i>, this finding addresses recent public anxiety and media debates that had questioned the safety of this popular antipyretic and analgesic medication.<\/p>\n<p data-path-to-node=\"4\">In the study, Hong Kong researchers utilized a specific statistical method to analyze more than 708,000 mother-child pairs. The researchers compared siblings within the same family where the mother took paracetamol during one pregnancy but not the other. This sibling-controlled approach allowed scientists to completely rule out shared genetic and familial environmental factors, which often lead to confounding results in other observational studies.<\/p>\n<p data-path-to-node=\"5\">In-depth data analysis revealed no association between paracetamol exposure and autism or ADHD, regardless of the dosage or the trimester of pregnancy in which the medication was taken. Even when one child was exposed to the drug in utero and their sibling was not, the risks of developing neurodevelopmental disorders were completely identical. The scientists explained that the weak associations noted in previous studies were not caused by the medication itself, but rather by the underlying maternal health conditions and familial factors that necessitated taking the drug in the first place.<\/p>\n<p data-path-to-node=\"6\">The World Health Organization and international regulatory bodies have long maintained that paracetamol is safe during pregnancy when used as indicated; however, this latest study provides robust scientific evidence to support that position. Notably, researchers tracked the children\u2019s development for up to 23 years in some cases, definitively confirming the accuracy of the diagnoses and long-term safety profiles.<\/p>\n<p data-path-to-node=\"7\">The researchers strongly caution pregnant women that leaving fever and pain untreated poses a far greater threat to the fetus. Arbitrarily turning to alternative medications like ibuprofen or opioid-based analgesics is scientifically proven to carry significantly more severe and hazardous risks for the future child&#8217;s health.<\/p>\n<p data-path-to-node=\"7\"><a href=\"https:\/\/jamanetwork.com\/journals\/jamainternalmedicine\/article-abstract\/2850975\" target=\"_blank\" rel=\"noopener\">JAMA<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>A new large-scale study analyzing two decades of accumulated medical data has confirmed that taking paracetamol (commonly known as Tylenol in the US) during pregnancy does not increase the risk of children developing autism or attention-deficit\/hyperactivity disorder (ADHD). Published in the prestigious scientific journal JAMA Internal Medicine, this finding addresses recent public anxiety and media [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":21370,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1594,1587],"tags":[4129],"class_list":["post-21371","post","type-post","status-publish","format-standard","has-post-thumbnail","category-news","category-research","tag-autizmi"],"acf":[],"_links":{"self":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/21371","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/comments?post=21371"}],"version-history":[{"count":1,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/21371\/revisions"}],"predecessor-version":[{"id":21374,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/posts\/21371\/revisions\/21374"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media\/21370"}],"wp:attachment":[{"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/media?parent=21371"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/categories?post=21371"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medscriptum.org\/en\/wp-json\/wp\/v2\/tags?post=21371"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}